CoreTissue BioEngineering
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2016Stage
Incubator/Accelerator | AliveAbout CoreTissue BioEngineering
CoreTissue BioEngineering is a medical device company that develops artificial ligaments derived from biological tissues.
CoreTissue BioEngineering Headquarters Location
Life Science Research Center 301 1-1-43 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045,
Japan
+81 03 (6228) 0053
Expert Collections containing CoreTissue BioEngineering
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CoreTissue BioEngineering is included in 3 Expert Collections, including Medical Devices.
Medical Devices
8,453 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Health IT
7,900 items
Latest CoreTissue BioEngineering News
Mar 16, 2022
March 15, 2022 11:19 PM Eastern Daylight Time YOKOHAMA, Japan--( BUSINESS WIRE )--CoreTissue BioEngineering Inc., a medical device company developing an artificial ligament derived from decellularized animal tissue, was accepted into Johnson & Johnson Innovation - JPOD @ Boston . CoreTissue BioEngineering will expand its footprint and accelerate business development in the US through its support team and select key opinion leaders (KOLs). About CoreTissue BioEngineering Inc. Based in Yokohama, Japan, CoreTissue BioEngineering, Inc. is a spinout company from Waseda University in Japan. We feel our team of Harvard-trained biomedical scientist, seasoned senior management in medical device development, and experienced clinical research professional has the right talents to carry this mission to potential success. Following our success in developing artificial ligament for ACL reconstruction surgery, we plan to further apply our technology platform to the development of medical devices for the broader human musculoskeletal system. CoreTissue BioEngineering has already validated a proof-of-concept of the product in an ovine large animal study with a prototype developed using these technologies. The company has received strong backing from the Japanese government, the Japan Agency for Medical Research and Development (AMED) for development from early feasibility through pivotal trial. Contacts
When was CoreTissue BioEngineering founded?
CoreTissue BioEngineering was founded in 2016.
Where is CoreTissue BioEngineering's headquarters?
CoreTissue BioEngineering's headquarters is located at Life Science Research Center 301, Yokohama.
What is CoreTissue BioEngineering's latest funding round?
CoreTissue BioEngineering's latest funding round is Incubator/Accelerator.
Who are the investors of CoreTissue BioEngineering?
Investors of CoreTissue BioEngineering include JLabs, Japan Science and Technology Agency, Teijin and WERU Investment.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.